Lyra pockets $29.5M to push ear, nose, throat applications of implant tech from Langer, Whitesides
Imagine having the worst cold of your life — and having it for 12 weeks straight.
Typically, physicians would try to manage the symptoms of chronic rhinosinusitis, like nasal discharge, obstruction or congestion, and facial pain, with a steroid spray. When that fails — as in about a third of cases — patients often consider surgery to open up access to the spray.
But with an implant developed by MIT’s Bob Langer and Harvard’s George Whitesides, an upstart wants to provide an alternative that would go where nasal sprays can’t.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
